Universitätsklinikum Freiburg

Herniation World Federation of Neurosurgical Societies Scale Improves Prediction of Outcome in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage (2022) Raabe A, Beck J, Goldberg J, Źgraggen WJ, Branca M, Marbacher S, D'Alonzo D, et al. Journal article Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”: [Annals of Oncology (2019), volume 30:1279-1288, (Annals of Oncology (2019) 30(1279-1288) (S0923753419312785)) (2022) Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al. Journal article, Erratum Surgical treatment of endometrial cancer (2022) Emons G, Brucker SY, Fleisch MC, Mueller M, Juhasz-Boess E, Kiesel L, Runnebaum IB, et al. Journal article Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea (2022) Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, et al. Journal article Internet- and mobile-based intervention for depression in adults with chronic back pain: A health economic evaluation (2022) Paganini S, Terhorst Y, Sander LB, Lin J, Schlicker S, Ebert DD, Berking M, et al. Journal article BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors (2022) Sevdali E, Block V, Lataretu M, Li H, Smulski CR, Briem JS, Heitz Y, et al. Journal article Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma (2022) Ravi VM, Will P, Kueckelhaus J, Sun N, Joseph K, Salié H, Vollmer L, et al. Journal article ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Valor L, Tascilar K, Krönke G, et al. Conference contribution CHARACTERIZATION OF RELAPSES IN PATIENTS WITH GIANT CELL ARTERITIS (GCA) PATIENTS- DATA FROM THE REAL-LIFE TREATMENT AND SAFETY (REATS)-GCA COHORT (2022) Schönau V, Corte G, Ott S, Tascilar K, Hartmann F, Manger B, Hellmich B, et al. Conference contribution Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial (2022) Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Celico C, Falautano M, et al. Journal article